APA (7th ed.) Citation

Almutair, A., Almutair, A., Almutair, A., Almulhem, B., Almulhem, B., & Almulhem, B. (2024, March). Semaglutide as a potential therapeutic alternative for HNF1B-MODY: A case study. Frontiers in Endocrinology.

Chicago Style (17th ed.) Citation

Almutair, Angham, Angham Almutair, Angham Almutair, Beshaier Almulhem, Beshaier Almulhem, and Beshaier Almulhem. "Semaglutide as a Potential Therapeutic Alternative for HNF1B-MODY: A Case Study." Frontiers in Endocrinology Mar. 2024.

MLA (9th ed.) Citation

Almutair, Angham, et al. "Semaglutide as a Potential Therapeutic Alternative for HNF1B-MODY: A Case Study." Frontiers in Endocrinology, Mar. 2024.